Applied DNA Sciences, Inc. (BNBX)

Applied DNA Sciences Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	3.74	3.43	13.37	18.17	9.03	1.93
Revenue Growth (YoY)	55.60%	-74.33%	-26.43%	101.25%	367.40%	-64.16%
Cost of Revenue	2.49	2.41	7.83	13.12	4.54	0.83
Gross Profit	1.25	1.02	5.53	5.05	4.48	1.1
Selling, General & Admin	11.43	11.45	12.75	15.1	12.85	10.03
Research & Development	3.46	3.59	3.74	3.93	4.16	3.32
Operating Expenses	14.9	15.04	16.49	19.02	17.01	13.64
Operating Income	-13.64	-14.02	-10.95	-13.97	-12.53	-12.53
Interest Expense	-	-	-	-	-	-0.12
Interest & Investment Income	0.31	0.18	0.08	0.01	0.01	-
Other Non Operating Income (Expenses)	0.16	6.76	0.86	5.69	-0.01	-0.38
EBT Excluding Unusual Items	-13.17	-7.09	-10.02	-8.27	-12.52	-13.03
Asset Writedown	-	-	-	-	-0.82	-
Other Unusual Items	-	-	-	-	-0.93	-
Pretax Income	-13.17	-7.09	-10.02	-8.27	-14.28	-13.03
Earnings From Continuing Operations	-13.17	-7.09	-10.02	-8.27	-14.28	-13.03
Minority Interest in Earnings	0.12	0.1	0.08	0	-0.01	0
Net Income	-13.19	-6.99	-9.95	-8.27	-14.29	-13.03
Preferred Dividends & Other Adjustments	-53.86	0.23	-	0.11	-	0
Net Income to Common	40.68	-7.23	-9.95	-8.38	-14.29	-13.03
Free Cash Flow	-13.26	-14.12	-7.36	-9.47	-15.94	-12.21
Gross Margin	33.42%	29.63%	41.39%	27.82%	49.66%	57.14%
Operating Margin	-364.52%	-408.72%	-81.94%	-76.89%	-138.76%	-648.98%
Profit Margin	1086.68%	-210.57%	-74.41%	-46.11%	-158.25%	-674.61%
Free Cash Flow Margin	-354.28%	-411.47%	-55.05%	-52.10%	-176.53%	-631.98%
EBITDA	-13.08	-13.33	-9.59	-12.68	-11.68	-12.25
EBITDA Margin	-	-	-71.75%	-69.79%	-129.41%	-
D&A For EBITDA	0.56	0.7	1.36	1.29	0.84	0.29
EBIT	-13.64	-14.02	-10.95	-13.97	-12.53	-12.53
EBIT Margin	-	-	-81.94%	-76.89%	-138.76%	-
Revenue as Reported	3.74	3.43	13.37	18.17	9.03	1.93
Advertising Expenses	-	0.12	0.19	0.29	0.28	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.